Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab Plus Standard Therapy in Chinese Paediatric Patients With Active Systemic Lupus Erythematosus
NCT04908865Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2021
- Primary completion
- May 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started Oct 2021; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04908865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04908865.